Clinical Trials Logo

Asymptomatic Amyloid-positive clinical trials

View clinical trials related to Asymptomatic Amyloid-positive.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02569398 Terminated - Clinical trials for Asymptomatic Amyloid-positive

An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia

EARLY
Start date: October 29, 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether treatment with atabecestat slows cognitive decline compared with placebo treatment, as measured by a composite cognitive measure, the Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive participants who are asymptomatic at risk for developing Alzheimer's dementia.